Victory Capital Management Inc Cue Biopharma, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$12.7 - $30.73 $54,737 - $132,446	-4,310 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$9.85 - $22.27 $5,141 - $11,624	522 Added 13.78%	4,310 $61,000
Q4 2019 Feb 04, 2020	BUY	$7.06 - $17.47 $2,174 - $5,380	308 Added 8.85%	3,788 $57,000
Q3 2019 Nov 12, 2019	BUY	$6.78 - $9.28 $23,594 - $32,294	3,480 New	3,480 $29,000

18.4M

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $22.3M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.